Fomepizole as an Adjunctive Treatment in Severe Acetaminophen Toxicity

Am J Emerg Med. 2020 Feb;38(2):410.e5-410.e6. doi: 10.1016/j.ajem.2019.09.005. Epub 2019 Nov 16.

Abstract

A 33-year-old male presented to the emergency department with a chief complaint of abdominal pain after taking #50 500 mg acetaminophen tablets over the preceding two days. He was tachycardic and tachypneic, and the initial labs were notable for acetaminophen level, 337 mg/L; AST, 137 IU/L; ALT, 194 IU/L; ABG pH, 7.24; and lactate, 4.1 mmol/L. The patient was started on IV N-Acetylcysteine (NAC) as well as given a single dose of 15 mg/kg fomepizole. The patient did remarkably well, with a peak AST of 198 IU/L, peak ALT of 301 IU/L, and peak INR of 3.1. Biochemical and animal data support fomepizole having hepatoprotective effects in acetaminophen poisoning. To our knowledge, this is the first human case of an intentional dual NAC/fomepizole regimen for severe acetaminophen toxicity.

Keywords: Acetaminophen; Fomepizole; Hepatotoxicity.

Publication types

  • Case Reports

MeSH terms

  • Acetaminophen / poisoning*
  • Acetylcysteine / administration & dosage
  • Adult
  • Analgesics, Non-Narcotic / poisoning*
  • Chemical and Drug Induced Liver Injury / drug therapy*
  • Chemical and Drug Induced Liver Injury / etiology
  • Drug Overdose / drug therapy*
  • Fomepizole / administration & dosage*
  • Humans
  • Male
  • Treatment Outcome

Substances

  • Analgesics, Non-Narcotic
  • Acetaminophen
  • Fomepizole
  • Acetylcysteine